LivaNova (LIVN) Long-Term Investments (2015 - 2026)
LivaNova (LIVN) posted Long-Term Investments of $38.3 million for Q1 2026, up 88.64% sequentially from $20.3 million in Q4 2025, and up 122.67% YoY from $17.2 million in Q1 2025.
LivaNova (LIVN) Long-Term Investments (2015 - 2026) Analysis & Trends
LivaNova has reported Long-Term Investments for 12 years, with the latest figure at $38.3 million in Q1 2026.
- Quarterly Long-Term Investments rose 122.67% year-over-year to $38.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.3 million (up 122.67% YoY) and the FY2025 annual result came in at $20.3 million, down 19.11% from the prior year.
- Long-Term Investments grew to $38.3 million in Q1 2026 per LIVN's latest filing, from $20.3 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $61.6 million in Q2 2022 and troughed at $16.2 million in Q2 2025.
- A 5-year average of $33.0 million and a median of $31.0 million in 2023 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2022 and 2025: Long-Term Investments soared 227.71% in 2022, then slumped 59.14% in 2025.
- Over 5 years, Long-Term Investments stood at $54.4 million in 2022, then sank by 58.0% to $22.8 million in 2023, then advanced by 9.81% to $25.1 million in 2024, then fell by 19.11% to $20.3 million in 2025, then jumped by 88.64% to $38.3 million in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $38.3 million, $20.3 million, and $28.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | - |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 57.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.29 Mn |
| Mar 31, 2026 | 38.28 Mn |
| Dec 31, 2025 | 20.29 Mn |
| Sep 30, 2025 | 28.01 Mn |
| Jun 30, 2025 | 16.16 Mn |
| Mar 31, 2025 | 17.19 Mn |
| Dec 31, 2024 | 25.08 Mn |
| Sep 30, 2024 | 35.37 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Mar 31, 2024 | 41.62 Mn |
| Dec 31, 2023 | 22.84 Mn |
| Sep 30, 2023 | 22.70 Mn |
| Jun 30, 2023 | 42.03 Mn |
| Mar 31, 2023 | 31.01 Mn |
| Dec 31, 2022 | 54.39 Mn |
| Sep 30, 2022 | 48.22 Mn |
| Jun 30, 2022 | 61.61 Mn |
| Mar 31, 2022 | 16.75 Mn |
| Dec 31, 2021 | 16.60 Mn |
| Sep 30, 2021 | 16.58 Mn |